Parimer is a U.S.-based, privately held contract research, development, and manufacturing organization (CDMO) specializing in chemical, pharmaceutical, and material development for human health. We help clients, from startups to global enterprises to navigate IND/CMC/ICH, FDA, ISO, and cGMP compliance.

Our core service lines include:

- R&D Services (e.g. custom synthesis, route development) - Manufacturing Capabilities (cGMP, scale-up, pilot, commercial) - Analytical Services (method development, stability studies, impurity profiling, etc.) - Polymers and specialty materials (for medical devices, adhesives, excipients) - Support for medical device-related chemistry (especially liquid medical devices) - Regulatory support, including IND, CMC, documentation, method validation, and FDA/EMA filing assistance

Parimer works with organizations across the scientific and product-development spectrum — from academic labs and biotech startups to global pharmaceutical and device manufacturers.

Yes. We custom-formulate and manufacture polymers, coatings, adhesives, and excipients, working from lab scale through pilot runs. We tailor properties like mechanical strength, thermal stability, cure behavior, and compatibility.

Parimer partners with universities and nonprofit research organizations to help translate discovery into development.

• We assist academic teams with chemical synthesis, material formulation, and feasibility studies for early-stage IP.

• Our scientists help prepare projects for technology transfer or commercial partnerships by supporting method development, validation, and reproducibility studies.

• Parimer has collaborated with organizations such as the Michael J. Fox Foundation, developing reagents for neurological research.

• We also provide documentation and analytical data that can strengthen grant proposals and licensing discussions.

Parimer was founded in 2018 as an independent, American-owned scientific services laboratory. We have no external shareholders or private equity interests, which allows us to stay nimble, competitive on pricing, and deeply client-focused.

We work with polymers such as polyesters, polyamides, polyimides, styrenics, acrylics, polyurethanes (and dispersions), polysaccharides, glycosamidoglycans, aminoplasts & formaldehyde resins. We use polymerization techniques including free radical, ring-opening, anionic, cationic, condensation, solution, emulsion, and melt condensation.

Our operations are U.S.-based to ensure regulatory, quality, and compliance rigor. We serve clients globally, supporting early-stage and clinical development projects through to commercial production.

Our analytical equipment includes:

• ICP-MS, GC-FID, GC-MS, HPLC, GPC, DSC, FTIR, XRF, DLS, Aerosizer, UV-Vis, Ion-selective electrodes, Inherent viscosity viscometer

• Synthetic equipment such as batch reactors from 100 mL to 600 L, liquid-liquid extraction units, nonmetallic filter presses, high-purity gas systems, distillation columns, reactors with wide temperature ranges, particle mills, etc.

We support: Universities & research institutions (helping translate discovery into development) Startups / biotech / emerging companies (helping move fast with constrained budgets) Pharmaceutical and device manufacturers needing regulatory, GMP, scale-up, or contract services.